RCRC IRB Announces a Name Change to Salus IRB and Expansion of Services for Multi-Site Clinical Trials

Salus IRB maintains a legacy of 28 years of continuous service coupled with expanded capabilities.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
Salus recognizes this changing scientific and business landscape and has a renewed commitment to nimble, customer focused service of the highest quality.

Austin, Texas (PRWEB) March 12, 2014

RCRC IRB announced today that its organization has changed its name to Salus IRB. The management, administrative staff, ownership structure, and review board memberships remain unchanged.

“Clinical trials are more complicated, costly, and fast-paced than ever before,” says Salus President Dwight DuBois. “Salus recognizes this changing scientific and business landscape and has a renewed commitment to nimble, customer focused service of the highest quality.”

Salus IRB is the direct successor to RCRC IRB, founded in 1985 with a specialization in Phase I clinical trials. Building on their expertise in Phase I clinical trials, Salus has recruited review boards, expanded its administrative staff, and refined its information technology systems to efficiently function as a central IRB for multi-site clinical trials, in a wide variety of therapeutic areas.

About Salus IRB

AAHRPP-accredited since 2009, Salus remains committed to the same high level of impeccable customer service and expertise their customers have always relied on. Salus IRB provides industry-leading turnaround times, with timely independent review board meetings and efficient administrative operations. Salus IRB has three boards, each meeting weekly, and employs a dedicated staff including the Executive Director, IRB Operations Manager, Quality Managers, Client Services Managers, and IRB Coordinators, as well as QC/QA and other administrative staff.


Contact